Pulse Biosciences
PLSE
54 hedge funds and large institutions have $51M invested in Pulse Biosciences in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 10 closing their positions.
38,100% more call options, than puts
Call options by funds: $382K | Put options by funds: $1K
0.55% less ownership
Funds ownership: 12.45% → 11.9% (-0.55%)
7% less funds holding
Funds holding: 58 → 54 (-4)
33% less capital invested
Capital invested by funds: $76M → $51M (-$25M)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
40% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.95M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$900K |
| 3 |
Renaissance Technologies
New York
|
+$759K |
| 4 |
Two Sigma Advisers
New York
|
+$693K |
| 5 |
Millennium Management
New York
|
+$334K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$2.97M |
| 2 |
BlackRock
New York
|
-$1.29M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$696K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$661K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$489K |
PLSE Hedge Fund Activity: Q2 2021 in Review
54 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2021, worth a combined $51M — down 33% from $76M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of PLSE and 6 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 12 added.
The largest buyer was Morgan Stanley, adding an estimated $1.95M. The largest seller was Tygh Capital Management, exiting entirely with an estimated $2.97M sold.
- 54 institutional investors held Pulse Biosciences (PLSE) as of Q2 2021, down from 58 in Q1 2021.
- Funds reported $51M of Pulse Biosciences stock for Q2 2021, down 33% quarter-over-quarter.
- 6 funds opened new Pulse Biosciences positions in Q2 2021 and 10 closed out, a net change of -4 holders.
- The largest Pulse Biosciences buyer in Q2 2021 was Morgan Stanley, an estimated $1.95M added.
- The largest Pulse Biosciences seller in Q2 2021 was Tygh Capital Management, an estimated $2.97M sold.
Based on aggregated 13F filings for Q2 2021.